Marchetti Jessica M, Blaine Tricia, Shelly Colleen E, Cherkerzian Sara, Hanley Nina, Murphy Lindsey, Gregory Katherine E
Departments of Nursing (Mss Marchetti, Blaine, Shelly, Hanley, and Murphy and Dr Gregory) and Pediatric Newborn Medicine (Drs Cherkerzian and Gregory), Brigham and Women's Hospital, Boston, Massachusetts; and Harvard Medical School, Boston, Massachusetts (Drs Cherkerzian and Gregory).
Adv Neonatal Care. 2023 Feb 1;23(1):93-101. doi: 10.1097/ANC.0000000000000989. Epub 2022 Mar 29.
Implementing innovative approaches to vascular access can be challenging in the newborn intensive care unit (NICU).
The purpose of this project was to describe the implementation of extended dwell peripheral intravenous (EPIV) catheters, a vascular access device not widely used in the NICU. The implementation involved (1) designing clinical criteria for EPIV catheter use, (2) education of vascular access NICU nurses, and (3) comparing clinical outcomes between vascular access devices (ie, PIV and EPIV catheters).
We developed evidence-based clinical criteria guiding the use of vascular access devices. We then developed an educational plan for NICU nurses focused on vascular access. Finally, we collected and compared demographic characteristics and clinical data on catheter type and placement attempts, dwell time, and clinical complications associated with each catheter.
EPIV catheters were implemented according to evidence-based criteria by a vascular access NICU nursing team. Fifteen percent of PIV catheter placements required 3 or more attempts compared with just 1% of EPIV catheter placement attempts. EPIV catheters had a longer median dwell time (3.5 vs 1 day) and fewer complications than PIV catheters (P < .001).
Implementation of an evidence-based approach to vascular access by a team of NICU nurses may improve clinical outcomes. EPIV catheters may be an appropriate alternative device to PIV catheters due to fewer placement attempts, longer dwell times, and overall fewer complications during use. Future vascular access research in the NICU may include a greater focus on innovative placement strategies, optimal maintenance and infection control, and prevention of complications.
在新生儿重症监护病房(NICU)实施创新的血管通路方法可能具有挑战性。
本项目的目的是描述延长留置外周静脉(EPIV)导管的实施情况,这是一种在NICU中未广泛使用的血管通路装置。实施过程包括(1)设计EPIV导管使用的临床标准,(2)对NICU血管通路护士进行培训,以及(3)比较血管通路装置(即外周静脉(PIV)导管和EPIV导管)之间的临床结果。
我们制定了基于证据的临床标准,以指导血管通路装置的使用。然后,我们为NICU护士制定了一项专注于血管通路的教育计划。最后,我们收集并比较了人口统计学特征以及与每种导管相关的导管类型、置管尝试次数、留置时间和临床并发症的临床数据。
NICU血管通路护理团队根据循证标准实施了EPIV导管。15%的PIV导管置管需要3次或更多次尝试,而EPIV导管置管尝试中这一比例仅为1%。EPIV导管的中位留置时间更长(3.5天对1天),且并发症比PIV导管更少(P <.001)。
NICU护士团队采用基于证据的血管通路方法可能会改善临床结果。由于置管尝试次数更少、留置时间更长且使用过程中总体并发症更少,EPIV导管可能是PIV导管的合适替代装置。未来NICU的血管通路研究可能会更加关注创新的置管策略、最佳维护和感染控制以及并发症的预防。